Pharmaceutical manufacturer.
H.R. 160, the Protect Medical Innovation Act.
S.1 49, the Medical Device Access and Innovation Protection. H.Res. 106, "Supporting Quality of Life for Prostate Cancer Patients."
H.R. 2, the "Medicare Access and CHIP Reauthorization Act.
21st Century Cures draft legislation, specifically those sections relating to regulatory and reimbursement policies affecting the biotechnology industry.
Policy issues relating to a proposed FDA regulation on generic drug labeling.
Policy issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act."
Policy issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Medical Device User Free program.
TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS CHRIS JONES ADAM HIGGINS